SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., president and chief executive officer, will present at Future Leaders in the Biotech Industry 2011 on Friday, April 15th in New York.

SuperGen's presentation will begin at 9:00 a.m. ET. A live webcast of the presentation will be available in the Investor Events section of the Company's website at www.supergen.com. The webcast will be archived for 30 days.

About SuperGen

SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit http://www.supergen.com.

Supergen, Inc. (MM) (NASDAQ:SUPG)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Supergen, Inc. (MM).
Supergen, Inc. (MM) (NASDAQ:SUPG)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Supergen, Inc. (MM).